메뉴 건너뛰기




Volumn 210, Issue 1, 2014, Pages 126-137

Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: Cross-season and cross-lineage protection with unchanged vaccine

(16)  Skowronski, Danuta M a,b   Janjua, Naveed Z a,b   Sabaiduc, Suzana a   De Serres, Gaston c   Winter, Anne Luise d   Gubbay, Jonathan B d,e   Dickinson, James A f   Fonseca, Kevin f,g   Charest, Hugues c   Bastien, Nathalie h   Li, Yan h   Kwindt, Trijntje L b   Mahmud, Salaheddin M i,j   Van Caeseele, Paul i,k   Krajden, Mel a,b   Petric, Martin a,b  


Author keywords

Influenza; Influenza A subtype; Influenza B lineage; Sentinel surveillance; Trivalent influenza vaccine; Vaccine effectiveness; Vaccines and immunisation

Indexed keywords

AMINO ACID; HEMAGGLUTININ; INFLUENZA VACCINE; TRIPLE INFLUENZA VACCINE; TRIPLE VACCINE; UNCLASSIFIED DRUG;

EID: 84893591409     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu048     Document Type: Article
Times cited : (106)

References (44)
  • 1
    • 33646152532 scopus 로고    scopus 로고
    • Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: Results from a sentinel physician pilot project in British Columbia, 2004-2005
    • Accessed 3 November 2013
    • Skowronski DM, Gilbert M, Tweed SA, et al. Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-2005. Can Commun Dis Rep 2005; 31:181-91. Available at: http://www.phac-aspc.gc.ca/publicat/ccdr- rmtc/05vol31/dr3118a-eng.php. Accessed 3 November 2013.
    • (2005) Can Commun Dis Rep , vol.31 , pp. 181-191
    • Skowronski, D.M.1    Gilbert, M.2    Tweed, S.A.3
  • 2
    • 33947131140 scopus 로고    scopus 로고
    • Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: Results from the 2005-2006 season of dual A and B vaccine mismatch in Canada
    • Skowronski DM, Masaro C, Kwindt TL, et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007; 25:2842-51.
    • (2007) Vaccine , vol.25 , pp. 2842-2851
    • Skowronski, D.M.1    Masaro, C.2    Kwindt, T.L.3
  • 3
    • 58849165403 scopus 로고    scopus 로고
    • Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007
    • Skowronski DM, De Serres G, Dickinson J, et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis 2009; 199:168-79.
    • (2009) J Infect Dis , vol.199 , pp. 168-179
    • Skowronski, D.M.1    De Serres, G.2    Dickinson, J.3
  • 4
    • 84861563523 scopus 로고    scopus 로고
    • Estimates of influenza vaccine effectiveness for 2007-08 from Canada's sentinel surveillance system: Cross-protection against major and minor variants
    • Janjua NZ, Skowronski DM, De Serres G, et al. Estimates of influenza vaccine effectiveness for 2007-08 from Canada's sentinel surveillance system: Cross-protection against major and minor variants. J Infect Dis 2012; 205:1858-68.
    • (2012) J Infect Dis , vol.205 , pp. 1858-1868
    • Janjua, N.Z.1    Skowronski, D.M.2    De Serres, G.3
  • 5
    • 77951745708 scopus 로고    scopus 로고
    • Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: Four observational studies from Canada
    • Skowronski DM, De Serres G, Crowcroft NS, et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: four observational studies from Canada. PLoS Med 2010; 7:e1000258.
    • (2010) PLoS Med , vol.7
    • Skowronski, D.M.1    De Serres, G.2    Crowcroft, N.S.3
  • 6
    • 79952060021 scopus 로고    scopus 로고
    • Effectiveness of AS03- adjuvanted pandemic H1N1 vaccine: Case-control evaluation based on sentinel surveillance system in Canada, autumn 2009
    • Skowronski DM, Janjua NZ, De Serres G, et al. Effectiveness of AS03- adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. Br Med J 2011; 342:c7297.
    • (2011) Br Med J , vol.342
    • Skowronski, D.M.1    Janjua, N.Z.2    De Serres, G.3
  • 7
    • 84863973361 scopus 로고    scopus 로고
    • A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-11 season
    • Skowronski DM, Janjua NZ, De Serres G, et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-11 season. Clin Infect Dis 2012; 55:332-42.
    • (2012) Clin Infect Dis , vol.55 , pp. 332-342
    • Skowronski, D.M.1    Janjua, N.Z.2    De Serres, G.3
  • 8
    • 84856769572 scopus 로고    scopus 로고
    • Statement on seasonal influenza vaccine for 2011-2012
    • National Advisory Committee on Immunization (NACI) Accessed 3 November 2013
    • National Advisory Committee on Immunization (NACI). Statement on seasonal influenza vaccine for 2011-2012. Can Commun Disease Rep 2011; 37:1-55. Available at: http://www.phac-aspc.gc.ca/publicat/ccdrrmtc/11vol37/acs-dcc-5/ index-eng.php. Accessed 3 November 2013.
    • (2011) Can Commun Disease Rep , vol.37 , pp. 1-55
  • 10
    • 79959716834 scopus 로고    scopus 로고
    • Serologic assays for influenza surveillance, diagnosis and vaccine evaluation
    • Katz JM, Hancock K, Xu X. Serologic assays for influenza surveillance, diagnosis and vaccine evaluation. Expert Rev Anti Infect Ther 2011; 9:669-83.
    • (2011) Expert Rev Anti Infect Ther , vol.9 , pp. 669-683
    • Katz, J.M.1    Hancock, K.2    Xu, X.3
  • 11
    • 84879209428 scopus 로고    scopus 로고
    • August. Accessed 3 November 2013
    • World Health Organization. WHOinformation for molecular diagnosis of influenza virus in humans - update. August 2011. Available at: http://www.who.int/influenza/resources/documents/molecular-diagnosis-influenza- virus-humans-update-201108.pdf. Accessed 3 November 2013.
    • (2011) WHOinformation for Molecular Diagnosis of Influenza Virus in Humans - Update
  • 12
    • 84155162558 scopus 로고    scopus 로고
    • Efficacy and effectiveness of influenza vaccines: A systematic review and metaanalysis
    • Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and metaanalysis. Lancet Infect Dis 2012; 12:36-44.
    • (2012) Lancet Infect Dis , vol.12 , pp. 36-44
    • Osterholm, M.T.1    Kelley, N.S.2    Sommer, A.3    Belongia, E.A.4
  • 13
    • 84859086467 scopus 로고    scopus 로고
    • Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012
    • pii=20129. Accessed 3 November 2013
    • Jimenez-Jorge S, de Mateo S, Pozo F, et al. Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012. Euro Surveill 2012; 17:pii=20129 (p 1-6). Available at: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20129. Accessed 3 November 2013.
    • (2012) Euro Surveill , vol.17 , pp. 1-6
    • Jimenez-Jorge, S.1    De Mateo, S.2    Pozo, F.3
  • 14
    • 84892775673 scopus 로고    scopus 로고
    • Influenza vaccine effectiveness in the 2011-2012 season: Protection against each circulating virus and the effect of prior vaccination on estimates
    • Ohmit SE, Thompson MG, Petrie JG, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014; 58:319-27.
    • (2014) Clin Infect Dis , vol.58 , pp. 319-327
    • Ohmit, S.E.1    Thompson, M.G.2    Petrie, J.G.3
  • 15
    • 84862874157 scopus 로고    scopus 로고
    • I-MOVE case-control studies team. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: Results from the I-MOVE multicentre case-control study 2011/12
    • pii=20146. Accessed 3 November 2013
    • Kissling E, Valenciano M, I-MOVE case-control studies team. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12. Euro Surveill 2012; 17:pii=20146 (p 1-7). Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20146. Accessed 3 November 2013.
    • (2012) Euro Surveill , vol.17 , pp. 1-7
    • Kissling, E.1    Valenciano, M.2
  • 16
    • 84873314436 scopus 로고    scopus 로고
    • Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: Results from the I-MOVE multicentre case-control study
    • pii=20390. Accessed 3 November 2013
    • Kissling E, Valenciano M, Larrauri A, et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill 2013; 18:pii=20390 (p 1-10). Available at: http://www.eurosurveillance. org/ViewArticle.aspx?ArticleId=20390. Accessed 3 November 2013.
    • (2013) Euro Surveill , vol.18 , pp. 1-10
    • Kissling, E.1    Valenciano, M.2    Larrauri, A.3
  • 17
    • 84873314743 scopus 로고    scopus 로고
    • Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratoryconfirmed influenza in primary care in the United Kingdom: Evidence of waning intra-seasonal protection
    • pii=20389. Accessed 3 November 2013
    • Pebody RG, Andrews N, McMenamin J, et al. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratoryconfirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection . Euro Surveill 2013; 18:pii=20389 (p 1-8). Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20389. Accessed 3 November 2013.
    • (2013) Euro Surveill , vol.18 , pp. 1-8
    • Pebody, R.G.1    Andrews, N.2    McMenamin, J.3
  • 18
    • 84874618250 scopus 로고    scopus 로고
    • Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine- mismatched influenza B/yamagata-lineage viruses in Taiwan, 2011-12 season
    • Accessed 3 November 2013
    • Lo Y-C, Chuang J-H, Kuo H-W, et al. Surveillance and Vaccine Effectiveness of an Influenza Epidemic Predominated by Vaccine- Mismatched Influenza B/Yamagata-Lineage Viruses in Taiwan, 2011-12 Season. PLoS One 2013; 8:e58222. Available at: http://www.plosone.org/article/info%3Adoi%2F10. 1371%2Fjournal.pone.0058222. Accessed 3 November 2013.
    • (2013) PLoS One , vol.8
    • Lo, Y.-C.1    Chuang, J.-H.2    Kuo, H.-W.3
  • 19
    • 84888024210 scopus 로고    scopus 로고
    • Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution
    • Koel BF, Burke DF, Bestebroer TM, et al. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 2013; 342:976-79.
    • (2013) Science , vol.342 , pp. 976-979
    • Koel, B.F.1    Burke, D.F.2    Bestebroer, T.M.3
  • 20
    • 84873306270 scopus 로고    scopus 로고
    • Statement on seasonal influenza vaccine for 2012-2013
    • National Advisory Committee on Immunization (NACI) Accessed 3 November 2013
    • National Advisory Committee on Immunization (NACI). Statement on seasonal influenza vaccine for 2012-2013. Can Commun Disease Report 2012; 38:1-36. Available at: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/12vol38/acs-dcc-2/ index-eng.php. Accessed 3 November 2013.
    • (2012) Can Commun Disease Report , vol.38 , pp. 1-36
  • 21
    • 0036924361 scopus 로고    scopus 로고
    • Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons
    • ShawMW, Xu X, Li Y, et al. Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology 2002; 303:1-8.
    • (2002) Virology , vol.303 , pp. 1-8
    • Shaw, M.W.1    Xu, X.2    Li, Y.3
  • 23
    • 77958553266 scopus 로고    scopus 로고
    • Clinical efficacy of cell-culture derived and egg-derived inactivated subunit influenza vaccines in healthy adults
    • Frey S, Vesikari T, Szymczakiewicz-Multanowska A, et al. Clinical efficacy of cell-culture derived and egg-derived inactivated subunit influenza vaccines in healthy adults. Clin Infect Dis 2010; 51:997-1004.
    • (2010) Clin Infect Dis , vol.51 , pp. 997-1004
    • Frey, S.1    Vesikari, T.2    Szymczakiewicz-Multanowska, A.3
  • 24
    • 84879212793 scopus 로고    scopus 로고
    • Comparing influenza vaccine efficacy against mismatched and matched strains: A systematic review and meta-analysis
    • Accessed 3 November 2013
    • Tricco AC, Chit A, Soobiah C, et al. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med 2013; 11:153. Available at: http://www.biomedcentral.com/1741-7015/11/ 153. Accessed 3 November 2013.
    • (2013) BMC Med , vol.11 , pp. 153
    • Tricco, A.C.1    Chit, A.2    Soobiah, C.3
  • 25
    • 80052925426 scopus 로고    scopus 로고
    • Influenza B/Victoria antigen induces strong recall of B/Yamagata but lower B/Victoria response in children primed with two doses of B/Yamagata
    • Skowronski DM, Hottes TS, De Serres G, et al. Influenza B/Victoria antigen induces strong recall of B/Yamagata but lower B/Victoria response in children primed with two doses of B/Yamagata. Ped Infect Dis J 2011; 30:833-9.
    • (2011) Ped Infect Dis J , vol.30 , pp. 833-839
    • Skowronski, D.M.1    Hottes, T.S.2    De Serres, G.3
  • 26
    • 84856270981 scopus 로고    scopus 로고
    • Antibody persistence and response to 2010-11 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children
    • Epub 2011 Nov 7
    • Gilca V, De Serres G, Hamelin M-E, et al. Antibody persistence and response to 2010-11 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children. Vaccine 2011; 30:35-41. Epub 2011 Nov 7.
    • (2011) Vaccine , vol.30 , pp. 35-41
    • Gilca, V.1    De Serres, G.2    Hamelin, M.-E.3
  • 27
    • 84893309583 scopus 로고    scopus 로고
    • Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: A population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons
    • Thompson MG, Li DK, Shifflett P, et al. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons. Clin Infect Dis 2014; 58:449-457.
    • (2014) Clin Infect Dis , vol.58 , pp. 449-457
    • Thompson, M.G.1    Li, D.K.2    Shifflett, P.3
  • 28
    • 84862690493 scopus 로고    scopus 로고
    • Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: Immunologic interactions and B/Yamagata dominance
    • Skowronski DM, Hamelin M-E, Janjua NZ, et al. Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominance. PLoS One 2012; 7:e38929.
    • (2012) PLoS One , vol.7
    • Skowronski, D.M.1    Hamelin, M.-E.2    Janjua, N.Z.3
  • 29
    • 84872224039 scopus 로고    scopus 로고
    • Persistence of influenza vaccine-induced antibody in lung transplant patients and healthy individuals beyond the season
    • Severson JJ, Richards KR, Moran JJ, Hayney MS. Persistence of influenza vaccine-induced antibody in lung transplant patients and healthy individuals beyond the season. Hum Vaccin Immunother 2012; 8:1850-3.
    • (2012) Hum Vaccin Immunother , vol.8 , pp. 1850-1853
    • Severson, J.J.1    Richards, K.R.2    Moran, J.J.3    Hayney, M.S.4
  • 30
    • 0022658480 scopus 로고
    • Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine
    • Clements ML, Murphy BR. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J Clin Microbiol 1986; 23:66-72.
    • (1986) J Clin Microbiol , vol.23 , pp. 66-72
    • Clements, M.L.1    Murphy, B.R.2
  • 31
    • 40049108737 scopus 로고    scopus 로고
    • Rapid decline of influenza vaccine-induced antibody in the elderly: Is it real, or is it relevant?
    • Skowronski DM, Tweed SA, De Serres G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? J Infect Dis 2008; 197:490-502.
    • (2008) J Infect Dis , vol.197 , pp. 490-502
    • Skowronski, D.M.1    Tweed, S.A.2    De Serres, G.3
  • 32
    • 84871049662 scopus 로고    scopus 로고
    • Kinetics of the antibody response to seasonal influenza vaccination among the elderly
    • Kositanont U, Assantachai P, Puthavathana P, Praditsuwan R. Kinetics of the antibody response to seasonal influenza vaccination among the elderly. Viral Immuno 2012; 25:471-6.
    • (2012) Viral Immuno , vol.25 , pp. 471-476
    • Kositanont, U.1    Assantachai, P.2    Puthavathana, P.3    Praditsuwan, R.4
  • 33
    • 84877257252 scopus 로고    scopus 로고
    • Influenza vaccine effectiveness in the community and the household
    • Ohmit SE, Petrie JG, Malosh RE, et al. Influenza vaccine effectiveness in the community and the household. Clin Infect Dis 2013; 56: 1363-69.
    • (2013) Clin Infect Dis , vol.56 , pp. 1363-1369
    • Ohmit, S.E.1    Petrie, J.G.2    Malosh, R.E.3
  • 34
    • 84880380404 scopus 로고    scopus 로고
    • Understanding suboptimal influenza vaccine effectiveness within the agent, host, and environment paradigm
    • Skowronski DM, Janjua NZ, De Serres G. Understanding suboptimal influenza vaccine effectiveness within the agent, host, and environment paradigm. Clin Infect Dis 2013; 57:476-7.
    • (2013) Clin Infect Dis , vol.57 , pp. 476-477
    • Skowronski, D.M.1    Janjua, N.Z.2    De Serres, G.3
  • 35
    • 84880366281 scopus 로고    scopus 로고
    • Stratified estimates of influenza vaccine effectiveness by prior vaccination: Caution required
    • Sullivan SG, Kelly H. Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required. Clin Infect Dis 2013; 57:474-6.
    • (2013) Clin Infect Dis , vol.57 , pp. 474-476
    • Sullivan, S.G.1    Kelly, H.2
  • 36
    • 0033601790 scopus 로고    scopus 로고
    • Protection against influenza after annually repeated vaccination: A metaanalysis of serologic and field studies
    • Beyer WE, de Bruijn IA, Palache AM, Westendorp RG, Osterhaus AD. Protection against influenza after annually repeated vaccination: a metaanalysis of serologic and field studies. Arch Intern Med 1999; 159:182-8.
    • (1999) Arch Intern Med , vol.159 , pp. 182-188
    • Beyer, W.E.1    De Bruijn, I.A.2    Palache, A.M.3    Westendorp, R.G.4    Osterhaus, A.D.5
  • 37
    • 0030849623 scopus 로고    scopus 로고
    • Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period
    • Keitel WA, Cate TR, Couch RB, Huggins LL, Hess KR. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine 1997; 15:1114-22.
    • (1997) Vaccine , vol.15 , pp. 1114-1122
    • Keitel, W.A.1    Cate, T.R.2    Couch, R.B.3    Huggins, L.L.4    Hess, K.R.5
  • 39
    • 70350574121 scopus 로고    scopus 로고
    • Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort
    • Irving SA, Donahue JG, Shay DK, Ellis-Coyle TL, Belongia EA. Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort. Vaccine 2009; 27:6546-9.
    • (2009) Vaccine , vol.27 , pp. 6546-6549
    • Irving, S.A.1    Donahue, J.G.2    Shay, D.K.3    Ellis-Coyle, T.L.4    Belongia, E.A.5
  • 41
    • 79952257810 scopus 로고    scopus 로고
    • H1N1 vaccination
    • Catalogue no. 82-003-XPE. Accessed 3 November 2013
    • Gilmour H, Hofmann N. H1N1 vaccination. Health Reports 2010 21(4). Statistics Canada, Catalogue no. 82-003-XPE. Available at: http://www.statcan. gc.ca/pub/82-003-x/2010004/article/11348-eng.pdf. Accessed 3 November 2013.
    • (2010) Health Reports , vol.21 , Issue.4
    • Gilmour, H.1    Hofmann, N.2
  • 42
    • 34547843673 scopus 로고    scopus 로고
    • Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness
    • Orenstein EW, De Serres G, Haber MJ, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007; 36:623-31.
    • (2007) Int J Epidemiol , vol.36 , pp. 623-631
    • Orenstein, E.W.1    De Serres, G.2    Haber, M.J.3
  • 43
    • 84884215211 scopus 로고    scopus 로고
    • The test-negative design: Validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomized double-blind placebocontrolled trials
    • pii: 20585. Accessed 7 December 2013
    • De Serres G, Skowronski DM, Wu XW, Ambrose CS. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomized double-blind placebocontrolled trials. Euro Surveillance 2013; 18. pii:20585 (p 1-9). Available at: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=20585. Accessed 7 December 2013.
    • (2013) Euro Surveillance , vol.18 , pp. 1-9
    • De Serres, G.1    Skowronski, D.M.2    Wu, X.W.3    Ambrose, C.S.4
  • 44
    • 51249116765 scopus 로고    scopus 로고
    • Population patterns of chronic health conditions, comorbidity and healthcare use in Canada: Implications for policy and practice
    • Broemeling AM,Watson DE, Prebtani F. Population patterns of chronic health conditions, comorbidity and healthcare use in Canada: implications for policy and practice. Healthcare Quarterly 2008; 11:70-6.
    • (2008) Healthcare Quarterly , vol.11 , pp. 70-76
    • Broemeling, A.M.1    Watson, D.E.2    Prebtani, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.